BioCentury
ARTICLE | Company News

Entelos Inc., UCB deal

January 28, 2008 8:00 AM UTC

UCB's UCB Pharma S.A. subsidiary and Entelos will use Entelos' PhysioLab platform to conduct research with an in silico model of rheumatoid arthritis (RA). Further terms were not disclosed. ...